Related Experiment Video
Updated: May 23, 2025

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
C-reactive protein point-of-care testing to guide antibiotic prescribing for respiratory tract infections
Carl Llor1,2,3
1Primary Care Research Institute Jordi Gol (IDIAP), Barcelona, Spain.
Introduction:
Antimicrobial resistance is strongly correlated with the volume of antibiotics used. Most antibiotics are prescribed in primary care, mostly for respiratory tract infections (RTIs), and are often unneeded.
Areas Covered:
The current knowledge regarding the use of C-reactive protein (CRP) rapid testing in primary care is outlined. A comprehensive literature search and narrative review of the evidence on CRP rapid testing for patients presenting with symptoms of RTIs was conducted to develop a holistic perspective on the subject. Relevant studies were identified through a PubMed search up to April 2025.
Expert Opinion:
CRP testing is an effective, cost-efficient tool to reduce unnecessary antibiotic use for lower RTIs in primary care. This test should be included in guidelines and implemented when a clinician is uncertain about the prognosis of an infection. It should complement history taking and clinical examination before deciding to prescribe antibiotics, primarily to rule out serious infections, but should never be used as a standalone test. To tackle antimicrobial resistance, the reduction of unnecessary antibiotic use in acute RTIs is optimized with clear guidance, advanced communication training for clinicians, and delayed antibiotic prescribing strategies when applicable.
Insights
C-reactive protein (CRP) rapid testing in primary care can reduce unnecessary antibiotic prescriptions for respiratory tract infections (RTIs). This cost-effective tool aids clinical decisions, combating antimicrobial resistance by optimizing antibiotic use.
Area of Science:
- Primary Care Medicine
- Infectious Diseases
- Clinical Diagnostics
Background:
- Antimicrobial resistance is a significant global health threat, closely linked to antibiotic consumption.
- The majority of antibiotic prescriptions are issued in primary care settings, often for viral respiratory tract infections (RTIs) where they are not indicated.
Purpose of the Study:
- To review the evidence on the utility of C-reactive protein (CRP) rapid testing in primary care for managing patients with RTIs.
- To assess the role of CRP testing in reducing unnecessary antibiotic prescribing and mitigating antimicrobial resistance.
Main Methods:
- A comprehensive literature search and narrative review of studies on CRP rapid testing for RTIs in primary care.
- Analysis of evidence up to April 2025, focusing on clinical utility and impact on antibiotic prescribing.
Main Results:
- CRP rapid testing is an effective and cost-efficient method to decrease unnecessary antibiotic use for lower RTIs in primary care.
- The test supports clinical decision-making, complementing patient history and examination to rule out serious infections.
Conclusions:
- CRP rapid testing should be integrated into clinical guidelines for managing RTIs when antibiotic prescription is uncertain.
- Implementation requires clear guidance, clinician training in communication, and consideration of delayed prescribing strategies to combat antimicrobial resistance effectively.
Related Concept Videos
Pneumonia III: Complications and Assessment
Real Time RT-PCR
The real-time quantification of the number of amplified products is...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...

